News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lux Biosciences Appoints To Board Of Directors David Guyer, SVLS Venture Partner And Former CEO Of Eyetech Pharmaceuticals, Inc. (EYET)


7/11/2006 12:55:45 PM

JERSEY CITY, N.J.--(BUSINESS WIRE)--July 11, 2006--Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, today announced the appointment of David R. Guyer, MD, venture partner, SV Life Sciences Advisers, to its Board of Directors.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES